Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 14, 2019; 25(2): 269-281
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.269
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.269
Figure 3 Colonic mucosal brain-derived neurotrophic factor mRNA levels in patients with diarrhea-predominant irritable bowel syndrome and healthy controls.
Mucosal brain-derived neurotrophic factor (BDNF) mRNA level is expressed as a fold-change relative to the average level of healthy controls. Diarrhea-predominant irritable bowel syndrome patients showed a significantly higher BDNF mRNA level than subjects in the control group (P = 0.001). IBS-D: Diarrhea-predominant irritable bowel syndrome; BDNF: Brain-derived neurotrophic factor.
- Citation: Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(2): 269-281
- URL: https://www.wjgnet.com/1007-9327/full/v25/i2/269.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i2.269